SOUTH SAN FRANCISCO, Calif., Jan. 12, 2025 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 43rd Annual J.P. Morgan Healthcare Conference…
Category: Uncategorized
SOUTH SAN FRANCISCO, Calif., Jan. 12, 2025 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 43rd Annual J.P. Morgan Healthcare Conference…
FY 2024 revenue of ~$611 million and Q4 2024 revenue of ~$165 million, representing 9% growth sequentially PLEASANTON, Calif., Jan. 12, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results…
FY 2024 revenue of ~$611 million and Q4 2024 revenue of ~$165 million, representing 9% growth sequentially PLEASANTON, Calif., Jan. 12, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results…
NEW YORK, Jan. 12, 2025 /PRNewswire/ — AVANT BIO, a growth equity firm dedicated to the enabling technologies transforming tomorrow’s therapeutics, today announced Sebastien Latapie has been promoted to Partner. This promotion reflects Mr. Latapie’s contributions to AVANT BIO’s…
RIYADH, Saudi-Arabien, 12. Januar 2025 /PRNewswire/ — Die mit Spannung erwartete vierte Ausgabe des Future Minerals Forum, das vom 14. bis 16. Januar 2025 in Riad stattfinden wird, soll große Vereinbarungen in Milliardenhöhe bekannt geben. Im Rahmen des Forums werden wichtige…
RIYADH, Arabie Saoudite, 12 janvier 2025 /PRNewswire/ — La quatrième édition très attendue du Future Minerals Forum, qui se tiendra du 14 au 16 janvier 2025 à Riyad, devrait annoncer des accords d’une valeur de plusieurs milliards d’euros. Le forum sera l’occasion de signer des accords…
NEW YORK, Jan. 12, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tungray Technologies Inc (NASDAQ: TRSG) resulting from allegations that Tungray Technologies may have…
NEW YORK, Jan. 12, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between May 6, 2021 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025…
Pricer, a global leader in digital shelf-edge solutions, and Focal Systems, a leader in shelf-edge AI, today announced a strategic collaboration to accelerate the digitization and optimization of the physical store for retailers worldwide. STOCKHOLM, Jan. 12, 2025 /PRNewswire/ — This…
